Titelia

Fund shareholders of Adicet Bio Inc

ISIN US0070022076 · United States · LEI 549300VRD2QO80WBOP18

Fund shareholders
14
Of which ETFs
1 13 other funds
Value held
≈ 4.7M $ 4.7M $ · 20.3K €
Share of capital
7.0 % of 9.4M shares on Aug 3, 2026
FundSharesValueWeight in fundShare of capital
Franklin Biotechnology Discovery Fund Franklin Strategic Series 225,1861.7M $0.16 %2.41 %as of Apr 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 213,1181.5M $0.00 %2.28 %as of Mar 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 99,248675.9K $0.00 %1.06 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 48,143349K $0.00 %0.51 %as of Feb 28, 2026
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS 18,112123.3K $0.00 %0.19 %as of Mar 31, 2026
Fidelity Total Market Index Fund Fidelity Concord Street Trust 17,363125.9K $0.00 %0.19 %as of Feb 28, 2026
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 11,18881.1K $0.00 %0.12 %as of Feb 28, 2026
Dimensional U.S. Small Cap ETF Dimensional ETF Trust 9,37270.8K $0.00 %0.10 %as of Apr 30, 2026
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS 6,04641.2K $0.00 %0.06 %as of Mar 31, 2026
U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 4,87036.8K $0.00 %0.05 %as of Apr 30, 2026
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 4,83935.1K $0.00 %0.05 %as of Feb 28, 2026
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds 1,48910.1K $0.00 %0.02 %as of Mar 31, 2026
Total Stock Market Index Trust John Hancock Variable Insurance Trust 2691.8K $0.00 %0.00 %as of Mar 31, 2026
VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. 20.3K €0.02 %as of Dec 31, 2025

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.

FundWeight in fund
Franklin Biotechnology Discovery Fund Franklin Strategic Series 0.16 %as of Apr 30, 2026
VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. 0.02 %as of Dec 31, 2025
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Mar 31, 2026
Dimensional U.S. Small Cap ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026
U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS 0.00 %as of Mar 31, 2026
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds 0.00 %as of Mar 31, 2026
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026
Total Stock Market Index Trust John Hancock Variable Insurance Trust 0.00 %as of Mar 31, 2026

Quarter after quarter

Each SEC quarterly data set, newest first. The change is read against the quarter before it.

QuarterShareholdersChangeSharesChange
2026Q213+3659,243+26.2 %
2026Q110522,305

Institutional managers

44 managers declare this company to the SEC (Form 13F); the 25 largest follow.

ManagerSharesValue
RA CAPITAL MANAGEMENT, L.P.1,182,6248.1M $as of Mar 31, 2026
ORBIMED ADVISORS LLC1,027,9447M $as of Mar 31, 2026
FRANKLIN RESOURCES INC626,5714.3M $as of Mar 31, 2026
CITADEL ADVISORS LLC381,8232.6M $as of Mar 31, 2026
Woodline Partners LP313,1242.1M $as of Mar 31, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.274,3751.9M $as of Mar 31, 2026
Prosight Management, LP250,2441.7M $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC232,5911.6M $as of Mar 31, 2026
Stonepine Capital Management, LLC221,9551.5M $as of Mar 31, 2026
Alyeska Investment Group, L.P.203,7991.4M $as of Mar 31, 2026
Carlyle Group Inc.184,2951.3M $as of Mar 31, 2026
NEXTBio Capital Management LP157,8271.1M $as of Mar 31, 2026
ACADIAN ASSET MANAGEMENT LLC118,138802 $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC101,135689K $as of Mar 31, 2026
DAFNA Capital Management LLC93,812638.9K $as of Mar 31, 2026
Burkehill Global Management, LP62,500425.6K $as of Mar 31, 2026
Rangeley Capital, LLC56,000381.4K $as of Mar 31, 2026
ADAR1 Capital Management, LLC53,827366.6K $as of Mar 31, 2026
Trexquant Investment LP43,666297.4K $as of Mar 31, 2026
TWO SIGMA INVESTMENTS, LP43,106293.6K $as of Mar 31, 2026
RBF Capital, LLC38,582262.7K $as of Mar 31, 2026
UBS Group AG38,368261.3K $as of Mar 31, 2026
JANE STREET GROUP, LLC37,084252.5K $as of Mar 31, 2026
BlackRock, Inc.36,585249.1K $as of Mar 31, 2026
STATE STREET CORP36,222246.7K $as of Mar 31, 2026

Declared shareholders of Adicet Bio Inc

2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.

ShareholderDeclared stakeShares
RA Capital Management, L.P. and 3 others12.30 %1,182,624as of Feb 17, 2026 · SCHEDULE 13G
Woodline Partners LP 3.30 %313,124as of Mar 31, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Fund shareholders of Adicet Bio Inc". https://titelia.com/en/stocks/adicet-bio-inc-US0070022076